Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
100 µM
Hemolytic
Cytotoxic
0% Hemolysis | 100 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity. | J Pept Sci | 2014